FDA issues Drug Safety Communication regarding an increased risk of fractures of the hip, wrist and spine associated with PPI use.
2010 – FDA issues Drug Safety Communication
Announcement Date: May 25, 2010
FDA issues Drug Safety Communication regarding an increased risk of fractures of the hip, wrist and spine associated with PPI use.